SBIR/STTR Research Award

Generation of antibodies to monitor Notch O-fucosylation in vivo

Award identifier 01678583cc46e6a683515a7af94c5b28a386aedddd3ca92fafb6bf570712197aAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$242,306

Program and phase

STTR · Phase I

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
GLYCOSCIENTIFIC, L.L.C.
Proposal award date
2016-09-26
Contract end date
2018-09-25
UEI
EUVNNWGFCA87
Solicitation number
PA15-270
Topic code
300

Research abstract

Project Summary Notch is a cell surface protein that has diverse roles in human biology at all stages of life Notch is modified by a number of sugar structures including a number that are termed O fucose Alteration of the pattern of O fucose structures found on Notch has significant effects on Notch function which in turn has been linked to both developmental and adult pathologies including cancer To date the study of O fucose structures on Notch has been severely hindered by a lack of research reagents that can specifically detect and monitor this structure Currently mass spectrometry is the method of choice for the analysis of O fucose glycans on Notch Although an extremely powerful technique it requires specialized instrumentation and expertise not available in most laboratories Development of sensitive and specific antibodies for O fucose glycans on Notch will provide many investigators with the tools to analyze O fucose glycans in vivo including clinical specimens We will utilize a newly developed methodology that enables reliable production of antibodies that can recognize distinct protein epitopes in the context of specific glycan modifications to produce antibodies to O fucose on Notch If successful these O fucose Notch specific antibodies will facilitate research on Notch in many laboratories and possibly could lead to new diagnostic and therapeutic tools Project Narrative Modification of the human Notch protein by a sugar structure termed O fucose is now under scrutiny for its role in cell biology and human diseases such as cancer There are currently no protein specific reagents to study O fucose We propose to develop site specific O fucose antibodies to the human Notch protein thereby providing valuable tools for the study of O fucosylation and Notch biology and their roles in human disease

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

12 SBIR/STTR records share this UEI (2011–2023). Reported award amounts total $5,523,413. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.